What Genesis Consortium does

Genesis Consortium is an investment alliance rather than an operating company: it is a coalition of venture capital funds and corporate venture arms co-created by SOSV (through its IndieBio program) and Mayfield, and committed to advancing human and planetary health through life-sciences and climate-tech investing. Current members include venture funds SOSV/IndieBio, Mayfield, DCVC, Litani, and Salt, alongside corporate venture arms at ADM and Syensqo Ventures. The consortium does not deploy its own capital product; instead it coordinates co-investment, deal-flow sharing, and ecosystem programming among member firms.

The consortium's primary activity is ecosystem-building rather than product delivery. It produces regular in-person events on life-sciences investing at IndieBio's event spaces in San Francisco and New York City, and participates in SOSV's annual Climate Tech Summit. IndieBio, as a co-creator, hosts the venues and co-produces programming. The alliance invites additional VCs and corporates committed to life-sciences investing to join, effectively serving as a curated entry point for strategic and financial capital into early-stage life-sciences and climate-tech startups.

Its business model is collaborative and not revenue-generating in a conventional sense: member VCs and corporates participate to source deals, share diligence, and access the consortium's curated programming and ecosystem. The consortium's investable base is anchored by SOSV's $306M Deep Tech Fund for Human and Planetary Health closed in April 2024, although this capital sits at the fund level rather than in a dedicated consortium vehicle. No separate management fees, carry structure, or LP terms for the consortium are disclosed.

Name

Genesis Consortium

Legal name

Genesis Consortium

Website

https://genesisconsortium.org

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Genesis Consortium is an alliance of VC and corporate-venture firms — anchored by SOSV/IndieBio and Mayfield, with DCVC, Litani, Salt, ADM, and Syensqo Ventures — that coordinates co-investment and events in life-sciences and climate-tech for early-stage founders.

Ownership category

akta.pro rank

Product category

Life Sciences Venture Capital

NAICS

Business Associations (813910), Business, Professional, Labor, Political, and Similar Organizations (8139)

SIC

Investment Advice (6282), Services-Membership Organizations (8600)

akta.pro primary industry

Corporate Accelerators & Startup Programs (FSANAHAD)

akta.pro secondary industries

Life Sciences & Biotechnology Congresses (THAHAJAB), Environmental & Climate Grantmaking Foundations (BPAGAKAM), Product & Innovation Summits (Roadmap, Launch Readiness, Innovation Days) (THAHAMAG)

Keywords

• Venture capital consortium
• Life sciences investing
• Deep tech venture capital
• Climate tech investing
• Early-stage venture capital

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels2 records

Core offering

The Genesis Consortium is an alliance of venture capital firms and corporate VCs that pools investment activity and ecosystem support for life science entrepreneurs and early-stage ventures focused on human and planetary health. Its operational deliverables include co-investment collaboration among member funds, regular in-person events on life sciences investing hosted at IndieBio's event spaces in San Francisco and New York City, and participation in SOSV's annual Climate Tech Summit. The consortium is open to additional members committed to life science investing.

Product overview

Genesis Consortium is an alliance of venture corporations and funds committed to advancing human and planetary health, rather than a product or technology company. It provides a foundation for life science entrepreneurs and the early-stage venture ecosystem by bringing together venture funds including SOSV, Mayfield, DCVC, Litani, Salt, and corporate VCs at ADM and Syensqo Ventures. The consortium organizes in-person events on life sciences investing at IndieBio's spaces in San Francisco and New York City, and participates in SOSV's annual Climate Tech Summit.

Differentiator

Problem solved

Functional benefit

Products and services

• Genesis Consortium Membership
• Life Sciences Investing Events

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• IndieBiocoreStrategic or Co-development PartnerIndieBio co-created the Genesis Consortium with SOSV and Mayfield. IndieBio produces regular in-person events on life sciences investing at its event spaces in San Francisco and New York City.

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Direct peers

• Mayfield: Co-founding venture fund member of the Genesis Consortium alongside SOSV; a long-established VC firm with active life sciences and human/planetary health investment mandates.
• SOSV: The anchor member and co-creator of the Genesis Consortium; a deep-tech VC firm operating the IndieBio accelerator and closing a $306M Deep Tech Fund for human and planetary health — the same thematic mandate as the consortium.
• Lux Capital: Early-stage VC firm with active investments across life sciences, climate, and deep tech; comparable to core Genesis members (DCVC, Salt, Litani) in mandate and stage.
• ARCH Venture Partners: Long-standing deep-tech and life sciences VC firm backing human and planetary health companies; comparable to Genesis's core VC members in stage, sector focus, and check size.
• IndieBio: Co-creator of the Genesis Consortium and SOSV's biotech accelerator program; produces the SF and NYC life sciences investing events that form the consortium's primary convening platform.
• Flagship Pioneering: Biotech creation-engine and VC firm focused on founding and scaling transformative human health and planetary health companies; comparable as a life sciences investment platform with thematic alignment to Genesis's mandate.
• Breakthrough Energy Ventures: Bill Gates-backed multi-LP venture fund focused on climate and human health technologies; comparable as a coalition-style VC vehicle pooling capital from strategic and financial investors to back deep-tech moonshots.
• The Engine (by MIT): Tough-tech investment vehicle built on a consortium of LPs backing deep-tech founders; structurally comparable to the Genesis Consortium's alliance model for funding frontier science and engineering ventures.

Broad incumbents

• Leaps by Bayer: Bayer's corporate venture arm investing in life sciences and health breakthroughs; comparable to Genesis corporate VC members (ADM, Syensqo Ventures) as a strategic CVC pursuing human-health mandates at scale.
• Alexandria Venture Investments: Strategic CVC arm of Alexandria Real Estate focused on life sciences investments across therapeutics, diagnostics, and platforms; comparable as a large, established life sciences CVC pursuing thematic health mandates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/GenConsortium

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genesis Consortium